ARQT Return on Tangible Equity | ARCUTIS BIOTHERAPEUTICS, INC.

ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Return on Tangible Equity

2026-06-30: Return Tang Equity 13.86%.
2026-03-31: Return Tang Equity -1.36%.
2025-12-31: Return Tang Equity -9.24%.
2025-09-30: Return Tang Equity -29.83%.

Complete source-backed return tang equity history.

Available history: 2018-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	13.86%
2026-03-31	-1.36%
2025-12-31	-9.24%
2025-09-30	-29.83%
2025-06-30	-72.03%
2025-03-31	-97.40%
2024-12-31	-94.58%
2024-09-30	-130.18%
2024-06-30	-110.43%
2024-03-31	-99.50%
2023-12-31	-318.79%
2023-09-30	-668.17%
2023-06-30	-448.90%
2023-03-31	-246.54%
2022-12-31	-148.61%
2022-09-30	-114.77%
2022-06-30	-133.09%
2022-03-31	-92.46%
2021-12-31	-69.32%
2021-09-30	-46.58%
2021-06-30	-36.26%
2021-03-31	-31.86%
2020-12-31	-50.14%
2020-09-30	-65.98%
2020-06-30	-43.30%
2020-03-31	-26.19%
2019-12-31	64.58%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-9.24%
2024-12-31	-94.58%
2023-12-31	-318.79%
2022-12-31	-148.61%
2021-12-31	-69.32%
2020-12-31	-50.14%
2019-12-31	64.58%
2018-12-31	80.27%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Enliven Therapeutics, Inc. (ELVN)	United States	$3.307B	-35.07
Amylyx Pharmaceuticals, Inc. (AMLX)	United States	$3.361B	-13.15
Arcus Biosciences, Inc. (RCUS)	United States	$3.188B	-8.52
Dyne Therapeutics, Inc. (DYN)	United States	$3.084B	-7.09
IDEAYA Biosciences, Inc. (IDYA)	United States	$3.540B	-20.52
Organon & Co. (OGN)	United States	$3.603B	17.03
Xenon Pharmaceuticals Inc. (XENE)		$3.684B	-14.27
ACADIA PHARMACEUTICALS INC (ACAD)	United States	$3.823B	11.45
PRECIGEN, INC. (PGEN)	United States	$2.757B	-12.94
AbCellera Biologics Inc. (ABCL)		$3.879B	-14.59